nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—Octreotide—MPO—ulcerative colitis	0.0125	0.519	CrCbGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CCL20—ulcerative colitis	0.00758	0.00776	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00753	0.00771	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00743	0.00762	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS1—ulcerative colitis	0.00734	0.306	CrCbGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.00732	0.0075	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.00707	0.00724	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00688	0.00705	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.00686	0.00703	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00679	0.00696	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCR2—ulcerative colitis	0.00675	0.00692	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00657	0.00674	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00653	0.00669	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00638	0.00654	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CCR6—ulcerative colitis	0.00635	0.00651	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.0063	0.00646	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.00627	0.00642	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00607	0.00622	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00602	0.00617	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.00593	0.00607	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.00589	0.00604	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00582	0.00596	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCR1—ulcerative colitis	0.00566	0.0058	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00562	0.00576	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00547	0.0056	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.0054	0.00554	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00537	0.0055	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCR1—ulcerative colitis	0.00523	0.00535	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.00519	0.00532	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.00519	0.00532	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00505	0.00517	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL20—ulcerative colitis	0.00497	0.00509	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—GHRL—ulcerative colitis	0.00484	0.00496	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00482	0.00493	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00478	0.00489	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.00474	0.00486	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL20—ulcerative colitis	0.00459	0.0047	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00444	0.00455	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCR2—ulcerative colitis	0.00443	0.00454	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00441	0.00452	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.00433	0.00443	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00426	0.00436	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00423	0.00433	CbGpPWpGaD
Vapreotide—Desmopressin—PTGS2—ulcerative colitis	0.0042	0.175	CrCbGaD
Vapreotide—SSTR5—GPCR ligand binding—CCR6—ulcerative colitis	0.00417	0.00427	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TLR4—ulcerative colitis	0.00412	0.00422	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCR1—ulcerative colitis	0.00411	0.00421	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL10—ulcerative colitis	0.00409	0.00419	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCR2—ulcerative colitis	0.00409	0.00419	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00407	0.00417	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.00397	0.00407	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—ICAM1—ulcerative colitis	0.00395	0.00405	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.00393	0.00403	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.0039	0.00399	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCR6—ulcerative colitis	0.00384	0.00394	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—PTGER4—ulcerative colitis	0.00367	0.00376	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00365	0.00374	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL20—ulcerative colitis	0.00361	0.0037	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.0036	0.00368	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.0035	0.00359	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—PTGER4—ulcerative colitis	0.00338	0.00347	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00337	0.00345	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—GHRL—ulcerative colitis	0.00336	0.00344	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCR2—ulcerative colitis	0.00322	0.0033	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.0032	0.00328	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCR1—ulcerative colitis	0.0032	0.00328	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—GHRL—ulcerative colitis	0.0031	0.00317	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCR6—ulcerative colitis	0.00303	0.0031	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IFNG—ulcerative colitis	0.00301	0.00308	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00295	0.00303	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCR1—ulcerative colitis	0.00291	0.00298	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—PTGS2—ulcerative colitis	0.00288	0.00295	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.00284	0.00291	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCL20—ulcerative colitis	0.00281	0.00288	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CXCL8—ulcerative colitis	0.0028	0.00286	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—ADRB2—ulcerative colitis	0.00278	0.00285	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.00272	0.00279	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCR1—ulcerative colitis	0.00268	0.00275	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL1B—ulcerative colitis	0.00268	0.00275	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL2—ulcerative colitis	0.00267	0.00274	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—PTGER4—ulcerative colitis	0.00266	0.00273	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.00265	0.00272	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—GNA12—ulcerative colitis	0.00264	0.00271	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.00263	0.00269	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCL20—ulcerative colitis	0.00259	0.00266	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—ADRB2—ulcerative colitis	0.00256	0.00263	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL20—ulcerative colitis	0.00255	0.00261	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.00254	0.0026	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MMP9—ulcerative colitis	0.00253	0.00259	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCR2—ulcerative colitis	0.0025	0.00257	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—GHRL—ulcerative colitis	0.00244	0.0025	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—GNA12—ulcerative colitis	0.00244	0.0025	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.00243	0.00248	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—GNA12—ulcerative colitis	0.0024	0.00246	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL20—ulcerative colitis	0.00235	0.00241	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR6—ulcerative colitis	0.00235	0.00241	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.00232	0.00238	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00231	0.00237	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCR2—ulcerative colitis	0.00227	0.00233	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	0.00224	0.00229	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.00222	0.00227	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GNA12—ulcerative colitis	0.00221	0.00227	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR6—ulcerative colitis	0.00217	0.00223	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	0.00214	0.0022	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR6—ulcerative colitis	0.00214	0.00219	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCR1—ulcerative colitis	0.00211	0.00216	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCR2—ulcerative colitis	0.0021	0.00215	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SEL1L—ulcerative colitis	0.00208	0.00214	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TGFB1—ulcerative colitis	0.00208	0.00213	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00207	0.00212	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCL8—ulcerative colitis	0.00205	0.0021	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCL20—ulcerative colitis	0.00204	0.00209	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—ADRB2—ulcerative colitis	0.00202	0.00207	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	0.002	0.00205	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—ulcerative colitis	0.00198	0.00203	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR6—ulcerative colitis	0.00197	0.00202	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—ulcerative colitis	0.00195	0.00199	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SEL1L—ulcerative colitis	0.00192	0.00197	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GNA12—ulcerative colitis	0.00192	0.00197	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00191	0.00196	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.00191	0.00196	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—GHRL—ulcerative colitis	0.0019	0.00194	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.0019	0.00194	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—PTGER4—ulcerative colitis	0.00188	0.00193	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL20—ulcerative colitis	0.00185	0.0019	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.00182	0.00186	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00176	0.00181	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—GHRL—ulcerative colitis	0.00175	0.00179	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GNA12—ulcerative colitis	0.00174	0.00179	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—PTGER4—ulcerative colitis	0.00174	0.00178	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—GHRL—ulcerative colitis	0.00172	0.00177	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCR1—ulcerative colitis	0.00172	0.00176	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TP53—ulcerative colitis	0.00172	0.00176	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR6—ulcerative colitis	0.00171	0.00175	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CALM3—ulcerative colitis	0.00167	0.00171	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCR2—ulcerative colitis	0.00165	0.00169	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00163	0.00167	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL6—ulcerative colitis	0.0016	0.00163	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—GHRL—ulcerative colitis	0.00159	0.00163	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCR1—ulcerative colitis	0.00158	0.00162	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00157	0.00161	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL6—ulcerative colitis	0.00157	0.00161	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—ulcerative colitis	0.00156	0.00159	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR6—ulcerative colitis	0.00155	0.00159	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CALM3—ulcerative colitis	0.00154	0.00158	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SEL1L—ulcerative colitis	0.00151	0.00155	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL20—ulcerative colitis	0.00151	0.00154	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—PTGER4—ulcerative colitis	0.00151	0.00154	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00145	0.00149	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ADRB2—ulcerative colitis	0.00143	0.00146	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GNA12—ulcerative colitis	0.00142	0.00145	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL20—ulcerative colitis	0.00139	0.00142	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—GHRL—ulcerative colitis	0.00138	0.00141	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—PTGER4—ulcerative colitis	0.00137	0.0014	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCR2—ulcerative colitis	0.00134	0.00138	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL8—ulcerative colitis	0.00134	0.00138	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00133	0.00137	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ADRB2—ulcerative colitis	0.00132	0.00135	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GNA12—ulcerative colitis	0.00131	0.00134	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	0.00128	0.00131	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR6—ulcerative colitis	0.00126	0.00129	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6—ulcerative colitis	0.00126	0.00129	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—GHRL—ulcerative colitis	0.00125	0.00128	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCR1—ulcerative colitis	0.00125	0.00128	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCR2—ulcerative colitis	0.00124	0.00127	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL8—ulcerative colitis	0.00124	0.00127	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—ADCY5—ulcerative colitis	0.00123	0.00126	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CALM3—ulcerative colitis	0.00121	0.00124	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ADCY5—ulcerative colitis	0.00121	0.00124	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MAML2—ulcerative colitis	0.0012	0.00123	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR6—ulcerative colitis	0.00117	0.00119	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—ADRB2—ulcerative colitis	0.00114	0.00117	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ADCY5—ulcerative colitis	0.00112	0.00114	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PTGER4—ulcerative colitis	0.00111	0.00114	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MAML2—ulcerative colitis	0.0011	0.00113	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL20—ulcerative colitis	0.00109	0.00112	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ADRB2—ulcerative colitis	0.00104	0.00106	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GNA12—ulcerative colitis	0.00103	0.00105	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PTGER4—ulcerative colitis	0.00103	0.00105	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—GHRL—ulcerative colitis	0.00102	0.00104	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CALM3—ulcerative colitis	0.000986	0.00101	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCR2—ulcerative colitis	0.000976	0.001	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL8—ulcerative colitis	0.000975	0.000999	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	0.000972	0.000995	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RIPK2—ulcerative colitis	0.000971	0.000995	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—ADCY5—ulcerative colitis	0.000969	0.000992	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—GHRL—ulcerative colitis	0.000939	0.000962	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR6—ulcerative colitis	0.000918	0.00094	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CALM3—ulcerative colitis	0.00091	0.000932	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RIPK2—ulcerative colitis	0.000896	0.000918	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ADCY5—ulcerative colitis	0.00088	0.000901	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MAML2—ulcerative colitis	0.00087	0.000891	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADRB2—ulcerative colitis	0.000843	0.000863	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—JAK2—ulcerative colitis	0.000831	0.000852	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PTGER4—ulcerative colitis	0.000808	0.000828	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADRB2—ulcerative colitis	0.000778	0.000797	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—JAK2—ulcerative colitis	0.000767	0.000786	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000759	0.000777	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—JAK2—ulcerative colitis	0.000755	0.000773	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—GHRL—ulcerative colitis	0.00074	0.000758	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2—ulcerative colitis	0.000725	0.000743	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CALM3—ulcerative colitis	0.000716	0.000734	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADCY5—ulcerative colitis	0.000715	0.000733	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RIPK2—ulcerative colitis	0.000706	0.000723	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL8—ulcerative colitis	0.0007	0.000717	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—JAK2—ulcerative colitis	0.000697	0.000714	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL8—ulcerative colitis	0.000689	0.000706	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2—ulcerative colitis	0.000669	0.000685	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADCY5—ulcerative colitis	0.00066	0.000676	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2—ulcerative colitis	0.000658	0.000675	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL8—ulcerative colitis	0.000636	0.000651	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADRB2—ulcerative colitis	0.000612	0.000627	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2—ulcerative colitis	0.000608	0.000622	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—JAK2—ulcerative colitis	0.000604	0.000619	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL8—ulcerative colitis	0.000551	0.000565	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—JAK2—ulcerative colitis	0.000548	0.000562	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2—ulcerative colitis	0.000527	0.00054	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADCY5—ulcerative colitis	0.00052	0.000532	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL8—ulcerative colitis	0.000501	0.000513	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2—ulcerative colitis	0.000478	0.00049	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JAK2—ulcerative colitis	0.000446	0.000457	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RELA—ulcerative colitis	0.000432	0.000442	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JAK2—ulcerative colitis	0.000411	0.000422	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL8—ulcerative colitis	0.000407	0.000417	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RELA—ulcerative colitis	0.000399	0.000408	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2—ulcerative colitis	0.000389	0.000398	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—ulcerative colitis	0.000387	0.000396	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL8—ulcerative colitis	0.000376	0.000385	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—ulcerative colitis	0.000368	0.000377	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NFKB1—ulcerative colitis	0.000364	0.000373	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2—ulcerative colitis	0.000359	0.000368	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—ulcerative colitis	0.000357	0.000366	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—ulcerative colitis	0.00034	0.000348	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NFKB1—ulcerative colitis	0.000336	0.000344	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STAT3—ulcerative colitis	0.000327	0.000335	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JAK2—ulcerative colitis	0.000324	0.000332	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RELA—ulcerative colitis	0.000314	0.000321	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—ulcerative colitis	0.000303	0.000311	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STAT3—ulcerative colitis	0.000302	0.000309	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL8—ulcerative colitis	0.000296	0.000303	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2—ulcerative colitis	0.000283	0.00029	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—ulcerative colitis	0.000281	0.000288	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—ulcerative colitis	0.00028	0.000287	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—ulcerative colitis	0.000267	0.000274	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NFKB1—ulcerative colitis	0.000265	0.000271	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TP53—ulcerative colitis	0.00025	0.000256	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STAT3—ulcerative colitis	0.000238	0.000244	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TP53—ulcerative colitis	0.00023	0.000236	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—ulcerative colitis	0.000229	0.000234	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—ulcerative colitis	0.00022	0.000226	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—ulcerative colitis	0.000211	0.000216	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TP53—ulcerative colitis	0.000181	0.000186	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—ulcerative colitis	0.000166	0.00017	CbGpPWpGaD
